TILS.L Regulatory News (TILS)

8 Mar 2005 11:15

ReGen Therapeutics PLC08 March 2005 ReGen Therapeutics Plc REGEN THERAPEUTICS PLC APPOINTS ADDITIONAL NON-EXECUTIVE DIRECTOR 8 March 2005 ReGen Therapeutics Plc (the 'Company') today announces that it has appointed DrPeter Garrod to be a non-executive director of the Company with immediateeffect. Peter Garrod commented "I was introduced to a natural product for the potentialtreatment of Alzheimer's disease in 1998. I have followed and supported ReGenwith absolute dedication in their quest for a treatment for this debilitatingcondition. I have always been at the forefront of advances in technology in my own fieldand feel that my input will enhance the progress and development of ReGen andwill endeavour to support the best interests of the shareholders". Percy Lomax the Chairman and Chief Executive of the Company commented "I welcomePeter Garrod to the Board. As a major shareholder his backing for the Board isimportant, but I believe that his scientific and business experience, togetherwith his enthusiasm to produce a better treatment for Alzheimer's disease willbe major assets to ReGen". Dr Garrod was born on 24th October 1950 and was educated at the London Hospital,part of the University of London. He graduated with a BDS and is a LDS of theRoyal College of Surgeons. He has been the Senior Partner of the Bower DentalCentre, which specialises in advanced dental cosmetic surgery, for the last 18years. There are no details to be disclosed pursuant to paragraphs (f)(iii) to(viii) of Schedule 2 to the AIM Rules. Dr Garrod currently holds and is beneficially interested in 36,000,000 ordinaryshares of the Company representing 10.5% of the current issued share capital ofthe Company. For further information, please contact:Andrew MarshallMarshall Robinson RoeTel No 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange